1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. NDC Product Code: 51759-202 Ajovy

NDC 51759-202 Ajovy

Fremanezumab-vfrm Injection Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 51759-202?
  4. Ajovy Uses
  5. Active Ingredients
  6. NDC to RxNorm Crosswalk
  7. Patient Education

Product Information

NDC Product Code:
51759-202
Proprietary Name:
Ajovy
Non-Proprietary Name: [1]
Fremanezumab-vfrm
Substance Name: [2]
Fremanezumab
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s): [4]
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Labeler Name: [5]
    Teva Pharmaceuticals Usa, Inc.
    Labeler Code:
    51759
    Product Label ID:
    98e344ea-5916-4947-b6f2-4a76ccc04b6b
    FDA Application Number: [6]
    BLA761089
    Marketing Category: [8]
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date: [9]
    03-29-2020
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 51759-202-10

    Package Description: 1 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER

    Price per Unit: $471.22485 per ML

    NDC Code 51759-202-11

    Package Description: 1 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER

    NDC Code 51759-202-22

    Package Description: 3 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER

    Price per Unit: $471.57274 per ML

    Product Details

    What is NDC 51759-202?

    The NDC code 51759-202 is assigned by the FDA to the product Ajovy which is a human prescription drug product labeled by Teva Pharmaceuticals Usa, Inc.. The generic name of Ajovy is fremanezumab-vfrm. The product's dosage form is injection and is administered via subcutaneous form. The product is distributed in 3 packages with assigned NDC codes 51759-202-10 1 container in 1 carton / 1.5 ml in 1 container, 51759-202-11 1 container in 1 carton / 1.5 ml in 1 container, 51759-202-22 3 container in 1 carton / 1.5 ml in 1 container. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Ajovy?

    This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Fremanezumab-vfrm belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.

    What are Ajovy Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    What is the NDC to RxNorm Crosswalk for Ajovy?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    * Please review the disclaimer below.

    Patient Education

    Fremanezumab-vfrm Injection


    Fremanezumab-vfrm injection is used to help prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Fremanezumab-vfrm injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
    [Learn More]


    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".